D. E. Shaw & Co., Inc. - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$86,083
-97.3%
67,782
-93.1%
0.00%
-100.0%
Q2 2023$3,243,081
-56.3%
985,739
-45.4%
0.00%
-62.5%
Q1 2023$7,423,067
-45.8%
1,806,099
-22.7%
0.01%
-46.7%
Q4 2022$13,688,603
-22.8%
2,335,939
-11.0%
0.02%
-28.6%
Q3 2022$17,739,000
+94.1%
2,624,223
+32.7%
0.02%
+90.9%
Q2 2022$9,138,000
+9.5%
1,977,930
-5.4%
0.01%
+37.5%
Q1 2022$8,343,000
+93.0%
2,090,866
+200.9%
0.01%
+166.7%
Q4 2021$4,322,000
+364.7%
694,903
+604.7%
0.00%
Q3 2021$930,000
+71.0%
98,605
+146.0%
0.00%
Q2 2021$544,000
-78.2%
40,085
-74.0%
0.00%
-100.0%
Q1 2021$2,493,000
-82.8%
154,071
-71.7%
0.00%
-84.6%
Q4 2020$14,472,000
+3.4%
543,875
-27.6%
0.01%
-7.1%
Q3 2020$13,997,000
-41.7%
751,726
-26.7%
0.01%
-51.7%
Q2 2020$24,007,000
+17683.0%
1,025,950
+4331.9%
0.03%
Q1 2020$135,000
-84.1%
23,149
-84.4%
0.00%
-100.0%
Q4 2019$848,000
+122.0%
148,147
-38.7%
0.00%
Q3 2019$382,000
-61.5%
241,566
-1.3%
0.00%
-100.0%
Q2 2019$991,000
+64.3%
244,816
+113.6%
0.00%0.0%
Q1 2019$603,000
+115.4%
114,612
+572.8%
0.00%
Q4 2017$280,00017,0340.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders